dr hans hammers discusses the clinical trial of nivolumab plus ipilimumab in renal cell carcinoma
Published 9 years ago • 1K plays • Length 3:09Download video MP4
Download video MP3
Similar videos
-
1:27
dr. hammers on nivolumab/ipilimumab data in rcc
-
11:42
nivolumab in renal cell carcinoma
-
44:03
updates on kidney cancer research with dr hans hammers
-
4:43
nivolumab in renal cell carcinoma
-
24:15
immunotherapy clinical trials with dr. hans hammers
-
6:52
nivolumab in renal cell carcinoma
-
3:19
radvax: nivolumab / ipilimumab with sbrt for metastatic renal cell carcinoma
-
3:26
nivolumab and cabozantinib versus standard of care in renal cell carcinoma
-
3:12
opdivo (nivolumab) the immunotherapy cancer treatment
-
6:33
one kidney cancer's patient's journey with belzutifan: from clinical trial to fda approval
-
5:09
recent advances in treating advanced kidney cancer
-
2:18
dr hans hammers discusses highlights from the thirteenth international kidney cancer symposium
-
4:06
dr hans hammers discusses how kidney cancer patients can take an active role in disease management
-
1:20
dr. hammers on immunotherapy combinations in kidney cancer
-
4:39
nivolumab and ipilimumab for metastatic kidney cancer
-
3:00
dosing medications for kidney cancer with dr. hans hammers of utsw
-
13:03
standard versus modified ipilimumab plus nivolumab for patients with advanced rcc
-
1:17
dr. hammers on the checkmate-214 study for rcc
-
1:21
dr. hammers on the long-term benefits of the checkmate-214 study in rcc
-
0:56
dr. hammers on next steps with immunotherapy in rcc
-
1:17
dr. hammers on the future of immunotherapy in rcc
-
1:33
checkmate 920: nivolumab plus ipilimumab for renal cell cancer